India  /  Published 24.06.22

'42 lakh deaths in India prevented by vaccines'

Covid-19 vaccines prevented over 42 lakh potential deaths in India in 2021, according to a modelling study published in The Lancet Infectious Diseases journal, which based its findings on estimates of...
By Our bureau and PTI in London

Health  /  Published 21.06.22

'Omicron less likely to cause long Covid'

The Omicron variant of the SARS-CoV-2 virus is less likely to cause long COVID than the Delta strain, according to a study published in The Lancet journal. Long COVID is defined as having new or ongo...
By Our Bureau, PTI in London

India  /  Published 25.05.22

'Antiviral drugs work against monkeypox'

Some antiviral medications might have the potential to shorten symptoms of monkeypox and reduce the amount of time a patient is contagious, according to a study of seven patients diagnosed with the ra...
By Our bureau and PTI in New Delhi

Opinion  /  Published 23.05.22

Breathe death: Economic cost of pollution

According to the recently-updated The Lancet Commission on Pollution and Health, approximately nine million global deaths in 2019 can be attributed to pollution. Of these, ambient air pollution was re...
By The Editorial Board

India  /  Published 18.05.22

Pollution caused over 23.5 lakh premature deaths

India saw over 23.5 lakh premature deaths due to pollution of all types -- including 16.7 lakh fatalities caused by air pollution -- in 2019, the highest among all countries globally, according to a n...
By Our Bureau, PTI in New Delhi


World  /  Published 12.05.22

Covid survivors show symptoms

More than half of people hospitalised with COVID-19 still have at least one symptom two years after they were first infected with the SARS-CoV-2 virus, according to the longest follow-up study publish...
By Our Bureau, PTI in Beijing

India  /  Published 09.03.22

Staying masked up post vax saves lives: Study

The researchers who have estimated the potential benefits of face masks in the US population at 70 to 90 per cent vaccination coverage said their results may apply to other countries, providing estima...
By Our Special Correspondent in New Delhi

India  /  Published 03.12.21

6 Covid boosters safe: Lancet

Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines, according to a study published in...
By Our Bureau, PTI in New Delhi

India  /  Published 24.11.21

Covaxin efficacy 50%: Lancet study

Two doses of Covaxin are 50 per cent effective against symptomatic COVID-19, according to the first real-world assessment of India's indigenous coronavirus vaccine published in The Lancet Infectio...
By Our Bureau, PTI in New Delhi

India  /  Published 28.08.21

Delta variant doubles hospitalisation risk, indicates large UK study

The delta coronavirus variant that was first detected in India and has spread across the world doubles the risk of hospitalisation compared with the alpha variant, UK researchers said on Friday after ...
By G.S. Mudur in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.